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In vivo detection of cucurbit[6]uril, 
a hyperpolarized xenon contrast 
agent for a xenon magnetic 
resonance imaging biosensor
Francis T. Hane1,2, Tao Li1, Peter Smylie1, Raiili M. Pellizzari1,2, Jennifer A. Plata1,2, 
Brenton DeBoef3 & Mitchell S. Albert1,2,4
The Hyperpolarized gas Chemical Exchange Saturation Transfer (HyperCEST) Magnetic Resonance 
(MR) technique has the potential to increase the sensitivity of a hyperpolarized xenon-129 MRI contrast 
agent. Signal enhancement is accomplished by selectively depolarizing the xenon within a cage 
molecule which, upon exchange, reduces the signal in the dissolved phase pool. Herein we demonstrate 
the in vivo detection of the cucurbit[6]uril (CB6) contrast agent within the vasculature of a living rat. Our 
work may be used as a stepping stone towards using the HyperCEST technique as a molecular imaging 
modality.
Hyperpolarized (HP) gas Chemical Exchange Saturation Transfer (HyperCEST) magnetic resonance imaging 
(MRI) contrast agents increase the sensitivity of HP gas MRI by several orders of magnitude1. These contrast 
agents can be conjugated with affinity tags to create xenon MR imaging biosensors to be used as a part of a 
potential molecular imaging modality2–4. Molecular imaging allows for the molecular detection, localization, 
and characterization of areas of pathology within the body using medical imaging5 without the need for invasive 
surgical biopsies. A number of imaging modalities have been demonstrated to be adept at molecular imaging 
including magnetic resonance imaging (MRI)6, positron emission tomography (PET)7, and single positron com-
puted tomography (SPECT)8; each are limited by their own specific characteristics. These imaging modalities 
rely on an injectable molecular probe which combines a detectable molecule and an affinity tag or antibody 
that binds to the molecule of interest within the body. Currently, the most common molecular imaging method 
is fluoro-deoxyglucose PET (FDG-PET). In FDG-PET, a radioactive 18F isotope is substituted for a hydroxyl 
group within deoxyglucose to create FDG and is used to detect areas of the body with abnormally high glucose 
metabolism which is an indicator of tumour neogenesis9. In a recent example of molecular imaging, Viola et al. 
used an iron nanoparticle displaying magnetic resonance, conjugated with an anti-amyloid oligomer antibody to 
detect and predict the onset of Alzheimer’s disease in rodents10. Hyperpolarized (HP) xenon MRI11 biosensors 
have the potential to characterize areas of pathologies within the body2. Hyperpolarization creates a nuclear 
spin polarization of xenon far beyond thermal equilibrium conditions, allowing a sensitivity increase of up to 
100,000 times above thermally polarized nuclei11. The basis of HyperCEST imaging biosensors is a cage molecule, 
which, when interacting with a HP xenon atom, acts as a HP xenon MRI contrast agent. The cage molecule is 
a supramolecular host that can reversibly encapsulate a guest HP xenon atom. The encapsulation and diffusion 
of 129Xe in and out of the cage molecule provides a unique and detectable magnetic resonance (MR) chemical 
shift frequency for the xenon atom inside the cage1,3,12–16. The HyperCEST MRI technique multiplies the signal 
enhancement of the hyperpolarization of 129Xe17 with the chemical exchange signal enhancement produced by the 
CEST MRI pulse sequence to provide a signal enhancement of up to one billion times above thermally polarized 
conditions1. To provide contrast, a HyperCEST saturation pre-pulse is applied at the chemical shift frequency of 
xenon within the cage molecule, thereby depolarizing the xenon atoms encapsulated by the cage. As the depolar-
ized xenon atoms exchange out of the cage molecule, they are replaced by polarized atoms from the reservoir of 
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dissolved 129Xe atoms in solution. Because of this diffusion, one Xe host can affect the magnetization of many Xe 
atoms causing a decrease of polarized nuclei in the dissolved-phase xenon reservoir, thereby reducing its signal 
intensity1. Similarly, in HyperCEST MR imaging, by comparing the “saturation” on-resonance xenon image with 
the ”control” off-resonance image, a HyperCEST saturation map can be created, showing the location of the MR 
active molecules18. By conjugating the cage molecule with an affinity tag, a HP xenon MR imaging biosensor can 
be created that can potentially detect spatially localized areas of pathology within the body18–21. A variety of xenon 
encapsulating molecules and structures have been proposed and tested in vitro including cryptophanes13,19–24, 
cucurbiturils14,25,26, gas vesicles18, lipid structures27,28 as well as others13,29. While cryptophanes have been the most 
popular xenon encapsulating molecules in the past, cucurbiturils have recently gained popularity in light of their 
superior exchange rates and HyperCEST characteristics26,30. Other similar methods of signal enhancement that 
rely upon chemical exchange, such as xenon transfer contrast (XTC), have also been reported31.
The HyperCEST technique provides high resolution MR images with a theoretical sensitivity comparable to 
Positron Emission Tomography (PET), but with the spatial resolution of MRI. Despite this promise, xenon MR 
imaging biosensors have yet to be detected within a living animal model following their intravenous administra-
tion. In this report, we demonstrate what we believe to be the first example of the in vivo detection of cucurbit[6]
uril (CB6), a HP Xe gas MRI contrast agent, using HyperCEST-enhanced 129Xe MRI, within the vasculature of a 
living rat. This MR active contrast agent could potentially be conjugated with an affinity tag to create such a HP 
xenon MR imaging biosensor. By having the rat breathe xenon gas, which dissolves in the blood and interacts 
with the injected CB6 cages circulating in the vasculature, we were able to successfully detect the presence of CB6 
in the brain, heart, liver, aorta, and the kidneys. These results are a stepping stone needed to translate this tech-
nique from in vitro studies to more advanced imaging biosensor studies.
Results
3 mL of 10 mM CB6 solution was injected into the tail vein catheter of a Sprague-Dawley (SD) rat and was allowed 
to bio-distribute for 30 minutes. An endotracheal tube was surgically placed in the trachea of the anaesthetized 
rat, and the rat was ventilated with 100% oxygen using a custom made ventilator. The rat was placed into a whole 
body custom made rat RF coil. Ten seconds prior to xenon MR acquisition, the rat was continuously ventilated 
with a gas mixture of 80% xenon/20% oxygen (Fig. 1). We acquired magnetic resonance spectra (MRS) (Fig. 2A 
and D) from both the abdomen and head of the rat. The MR spectrum from the abdomen revealed three resolva-
ble peaks at + 184 ppm, + 192.5 ppm, and + 207 ppm with respect to the 129Xe gas phase chemical shift frequency 
(referenced to 0 ppm) (Fig. 2A). The chemical shift of these peaks approximate those that have been previously 
assigned to fat, lung parenchyma, and blood respectively32, although interspecies differences have been known 
to occur32. We did not observe a peak corresponding to the 129Xe-CB6 peak, as previously reported14. We attrib-
ute this to a variety of susceptibility and line broadening effects occurring in vivo. By applying a HyperCEST 
pre-pulse train at the known chemical shift frequency of 129Xe-CB6 (+ 123.4 ppm)16, we acquired an MR spectrum 
with a 22% reduction in signal intensity compared to the off-resonance control spectrum (Fig. 2C). We repeated 
this technique after the rat was placed into a custom made rat head RF coil (Fig. 2D–F). By applying a HyperCEST 
pre-pulse (+ 123.4 ppm), we observed a 55% reduction in signal intensity of the MR signal from the brain of the 
rat (Fig. 2F). We observed four xenon peaks at + 185 ppm, + 191 ppm, + 193 ppm, + 205 ppm. Based on previously 
report results33,34, we assign these peaks to muscle, white matter, grey matter, and red blood cells, respectively.
We acquired 1 H turbo spin echo (TSE) MR images to correlate the xenon signal with its anatomical location. 
Immediately prior to 129Xe image acquisition, the rat was ventilated with xenon as described above. The imag-
ing sequence began with a saturation pre-pulse consisting of sixteen 20 ms 3-lobe sinc pulses with a 3 sec pulse 
interval applied at on-resonance (+ 123.4 ppm) and off-resonance (+ 260 ppm) chemical shift frequencies. 129Xe 
gradient echo (GE) images of the abdomen and brain were acquired with both off-resonance and on-resonance 
saturation pre-pulses (Fig. 3A,B,D,E respectively).
The off-resonance MR images revealed the distribution of xenon throughout the areas of the rat anatomy 
known to have high perfusion rates such as the brain, aorta, liver, kidney, lungs and heart (Fig. 3A). By apply-
ing the HyperCEST saturation pulses we observed a reduction in signal in areas containing the CB6 molecules 
(Fig. 2B and E). By comparing the on-resonance control images with the off-resonance HyperCEST images 
(Fig. 2C and F), and registering to the 1 H localizer images, we selectively imaged the areas of CB6 molecules that 
were localized to the brain, heart, lungs, liver, aorta, and kidneys (Fig. 4). We also created a HyperCEST saturation 
map in the brain of the rat (Fig. 4B) which demonstrates the localization of CB6 within the brain.
We also conducted a number of control experiments with sham IV injections to ensure that the results that 
we observed are solely attributable to the location of the cage molecule within the body of the rat. First, we repli-
cated our experiment by injecting 3 mL of PBS buffer containing no CB6 (Supplementary Information Figure S1). 
We observed an almost identical xenon signal from the brain regardless of off- or on-resonance saturation 
pre-pulses. A saturation map created from these images yielded almost no HyperCEST signal (Figure S1C). This 
absence of signal in the absence of a HyperCEST contrast agent provides evidence that the images we document 
in this report can be attributed to the presence of the CB6 within the body of the rat. We then compared MR 
images acquired with saturation pre-pulses at an off-resonance frequency and a saturation pre-pulse train at the 
chemical shift offset of xenon interacting with brain matter (Figure S2). We observed a complete xenon signal 
depletion (Figure S2B and C) indicating that the HyperCEST effect observed in Fig. 3 can be attributed solely 
to the HyperCEST effect of the Xe-CB6 interaction and cannot be explained by other processes such as general 
xenon depolarization or image processing induced artifacts.
Discussion
In in vitro HyperCEST studies, the reduction in the signal of the dissolved phase reservoir of xenon is typically 
measured. In in vivo studies such as these, no such “dissolved pool” exists to measure the HyperCEST depletion; 
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rather than being dissolved in solution, the xenon is dissolved in various tissues and bodily fluids such as lipids 
in brain matter and blood. It is these pools of xenon interacting with the tissue that constitutes a dissolved phase 
pool. Xenon atoms diffuse in and out of the CB6 cage, becoming depolarized as they are saturated by the satura-
tion pre-pulse. The saturated xenon atoms, however, continue to interact with various tissues in the body. Despite 
these additional complexities, our work is an important first proof-of-principle demonstration that HyperCEST 
imaging is possible in complex biological environments.
We faced a number of challenges to demonstrate the detection of CB6 in vivo. In our initial imaging biosensor 
experiments, we conjugated a cryptophane cage molecule with a PK11195 inflammation detecting affinity tag. We 
were, however, unable to synthesize sufficient quantities of this imaging biosensor to make in vivo experiments 
feasible35. Realizing these limitations, we recently switched our attention to the CB6 supramolecular cage mole-
cule16. By using commercially available CB6, which we and others14,16 determined to exhibit a HyperCEST effect, 
we were able to inexpensively obtain sufficient quantities of the contrast agent for in vivo HP Xe MRI. Second, 
appropriate radio frequency coils which maximize the form filling factor had to be constructed. We built custom 
dual-quadrature, dual-tuned (1H/129Xe) quadrature coils which maximized the filling factor, and therefore the 
SNR, for rat models. Lastly, a saturation pulse sequence with sufficient specificity for the cage-encapsulated xenon 
was required. The clinical scanner we used did not originally allow for continuous saturation or a long application 
of saturation pre-pulse trains (500 ms). We modified the scanner software and MRI pulse sequence to allow for 
such saturation pre-pulse trains (3 s). Even then, we were initially limited to a short (< 50 ms) pulse length, for 
each individual pulse, which yielded insufficient HyperCEST depletion for imaging purposes. Following addi-
tional software modifications, we were able to increase the saturation pulse train length available by the scanner 
to that which we have described in this work. All of the spectroscopy and imaging experiments described in this 
Figure 1. (A) Xenon is polarized using Spin Exchange Optical Pumping (SEOP). In SEOP, xenon flows into 
a chamber containing rubidium gas vapor in the presence of a magnetic field. The rubidium is excited by a 
laser. Xe colliding with the Rb results in a spin exchange, whereby a greater proportion of Xe atoms are in the 
lower energy spin state (red). (B) The CB6 solution is intravenously injected into the tail vein and allowed to 
bio-distribute. (C) The rat is mechanically ventilated with a mixture of 80% xenon/20% oxygen. The rat inhales 
HP Xe gas which enters the vasculature via the lungs. The HP Xe interacts with the CB6 cage, diffusing in and 
out of the cage. Figure created by Craig Christoff of Cryodragon Inc. (D) A HyperCEST saturation pre-pulse 
is applied at the chemical shift frequency of the Xe-CB6 complex (123.4 ppm), depolarizing the Xe in the cage 
(blue). Because of the exchange of xenon in and out of the cage molecule there is in a reduction of signal in the 
dissolved reservoir. (E) During acquisition, an RF pulse is applied at the chemical shift of Xe-CB6, depolarizing 
only the Xe within the CB6 cage. As the depolarized xenon exchanges out of the CB6 cage, it reduces the pool 
of polarized (detectable) Xe atoms (red). The reduction of MR signal compared to a control signal indicates the 
presence of CB6 cages.
www.nature.com/scientificreports/
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Figure 2. MR spectra and images for the abdomen of a Sprague-Dawley rat following IV injection of 3 mL 
of 10 mM CB6 solution. (A) Free induction decay (FID) spectrum acquired in the abdominal region following 
the application of an off-resonance (control) pre-pulse at + 260 ppm. (B) FID spectrum acquired following 
the application of an on-resonance HyperCEST pulse at + 123.4 ppm. Notice the reduction in the SNR of the 
primary peak indicating a HyperCEST depletion. (C) HyperCEST depletion spectrum of the abdomen showing 
the HyperCEST effect as a function of the chemical shift offset of the saturation pulse. Notice a HyperCEST 
effect at the CB6 resonance frequency (+ 123.4 ppm) compared to its absence in the control experiment.  
(D–F) Identical to (A–C) but acquired at the head.
Figure 3. Xe MR images of a Sprague-Dawley rat following IV injection of 3 mL of 10 mM CB6 solution. 
(A) A 2D gradient echo (GE) Xe MR image of the abdomen following the application of an off-resonance pre-
pulse (+ 260 ppm). (B) Same as (A) but following an on-resonance HyperCEST saturation pre-pulse (+ 123.4), 
which destroys the polarization of the Xe in the CB6 cage. As these depolarized Xe atoms leave the cage, they 
reduce the pool of polarized Xe in the blood, thereby reducing the MR signal. (C) A saturation map constructed 
by subtracting, pixel-by-pixel, the on-resonance HyperCEST image from the off-resonance control image, and 
dividing by the off-resonance control image. This measures signal depletion and indicates the location of the 
CB6 cage molecule. (D–F) Same as images (A–C) but images acquired of the rat brain.
www.nature.com/scientificreports/
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study were performed on a clinical 3 T MRI scanner, which bodes well for translation of HP xenon biosensor MRI 
to clinical applications.
Future advancements will include longer pulse lengths that still respect the specific absorption rate (SAR) 
limitations for mammalian subjects, which will yield higher depletion and therefore sensitivity. Conjugation 
of xenon-encapsulating cage molecules with affinity tags to specifically detect pathological molecules has also 
proven to be difficult, requiring many steps with low yields21. Future work will focus on conjugating a cage mole-
cule to an affinity tag with sufficiently high yield to be feasible for detection of disease.
One of the limitations of our study is that we were unable to determine how much of the CB6 actually inter-
acts with xenon and to what extent the CB6 interacts with endogenous tissue. Hydrophobic cage molecules may 
have a high affinity for the lipid cell surface, resulting in impaired xenon diffusion in and out of the cage cavity36. 
Another limitation of our study is that since our experiments were conducted in vivo on a clinical MR scanner, 
optimized for medical imaging, we were unable to acquire typical depletion spectra that nicely fit exponential 
Lorenzian curves as described in other works23,30. Future experiments will focus on optimization of the imaging 
parameters for in vivo MR imaging biosensor studies.
In the future, by combining the MR active cage molecules with an antibody or other affinity tag, a HP xenon 
MR imaging biosensor could be created to spatially localize areas of pathology within the body. Such biosensors 
have the potential to provide the imaging based support for personalized medicine. Personalized medicine and 
precision radiology require specialized imaging modalities that provide imaging biomarkers37. These imaging 
biomarkers may allow for the stratification of patients according to their phenotypic characteristics, which is a 
requirement of personalized medicine.
With the demonstration of a HP xenon MRI contrast agent in vivo, we eagerly anticipate the development 
and successful in vivo demonstration of targeted HP gas MR imaging biosensors that can image localized disease 
within whole, living organisms.
Methods
Sample Preparation. A 10.0 mM solution of cucurbit[6]uril (CB6) was made by dissolving 100 mg of CB6 
(Sigma-Aldrich, St. Louis, USA) in 10 mL of 1X phosphate buffered saline (PBS) at pH 7.2. The mixture was 
heated and stirred for approximately 10 minutes to aid in dissolving the CB6. The solution was allowed to cool to 
room temperature.
Rat Preparation. All animal procedures were conducted in accordance with the guidelines set out by the 
Canadian Council on Animal Care and approved by the Lakehead University Animal Care Committee under 
animal utilization protocol #1463772. Sprague-Dawley rats (n = 6) (Charles River, Sherbrook QC) weighing 
between 300–400 g were anesthetized using 3 LPM of isoflurane until their corneal reflex became absent. Once 
the rats were anaesthetized, a tail vein catheter was placed and an intravenous (IV) infusion of propofol was 
started (45 mg/kg/hr). A second tail vein catheter (in the other tail vein) was inserted for IV access for CB6 
administration.
A midline incision was made in the neck of the rat and the trachea localized. A 1 mm semi-circumscribed inci-
sion was made in the trachea, and an endotracheal catheter was inserted into the trachea. The neck was sutured 
closed. The endotracheal tube was connected to a custom made ventilator38 and the rat was placed on oxygen at 
60 breaths per minute with a tidal volume of 5 mL.
3 mL of 10 mM CB6 solution was injected over 2 minutes into the tail vein catheter. The rats were placed inside 
custom dual-tuned (1H/129Xe) birdcage RF coils. Two 8-rung qual-quadrature, dual-tuned birdcage coils were 
constructed for rat abdomen and brain imaging, each optimized in size for a maximized filling factor for respec-
tive regions of interest. Both coils adopted a four-end ring design to obtain 129Xe-1H dual-nuclei imaging ability, 
facilitating accurate image registration. Following data acquisition, the rats were euthanized by IV injection of 
pentobarbital.
Figure 4. (A) HyperCEST saturation map of a rat abdomen zoomed in and overlaid on a 1H MR image 
showing the location of the CB6 cage contrast agent. Accumulation is noted in the heart (top of image), lungs, 
liver, aorta (midline), and the kidneys (lateral to aorta, upper abdominal quadrants). (B) Same as (A) but of the 
rat brain.
www.nature.com/scientificreports/
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Magnetic Resonance Spectroscopy and Imaging. A Philips Achieva 3 T clinical scanner, operating at 
the 129Xe resonance frequency of 35.33 MHz, was used to acquire all MR spectra and MR images. 129Xe gas was 
polarized to 30% using a Xemed polarizer (Xemed, Durham, NH). The magnetic field of the Philips Achieva 3 T 
scanner was shimmed on the 1H signal using a mineral-oil phantom of approximately the same size as the rat to 
correct for B0 inhomogeneities to improve the spectral resolution of the acquisitions. T2-weighted 1H turbo spin 
echo (TSE) multi-slice images (TR = 2 s, TE = 40 ms, flip angle = 12 degrees, slice thickness 2 mm) were acquired 
from the abdominal and brain regions of the rat with a field of view of 150 mm × 150 mm and a matrix size of 
256 × 256, yielding an in-plane resolution of 0.586 mm.
30 minutes following CB6 IV injection, the ventilator was set to dispense xenon to the rat. A 5 second xenon 
wash in period was provided followed by the continuous administration of an 80% xenon/20% oxygen mix-
ture for the duration of the MR scan. 15 seconds following the beginning of xenon ventilation, a series of FID 
spectra were acquired with saturation pre-pulses (16 × 20 ms 3-lobe sinc pulses with 3 ms pulse intervals) at 
various chemical shift offsets. The FID spectra were acquired using a simple pulse-acquire sequence, with a selec-
tive “spredrex” excitation pulse of a length of 5 ms and bandwidth of 2849 Hz (80.6 ppm at 3 T)39. The receiver 
bandwidth was 32 kHz (906 ppm at 3 T), which is sufficiently high to prevent xenon gas peak from aliasing back 
into the acquired spectrum. The data sampling number was 2048, yielding a spectral resolution of 0.44 ppm. 
HyperCEST depletion was calculated at each chemical shift offset by subtracting the on-resonance HyperCEST 
SNR from the average of control off-resonance SNR’s (+ 260 ppm) and divided by the control off-resonance SNR. 
The HyperCEST depletion values were plotted against the chemical shift offset. Xenon 2D gradient echo images 
were acquired with a field of view of 150 mm × 150 mm with a matrix size of 64 × 64 and an in-plane resolution 
of 2.34 mm, slice thickness of 30 mm, TR = 197 ms, TE = 1.67 ms, flip angle of 40 degrees, bandwidth 300 Hz/
pixel. On- and off-resonant saturation pre-pulses (+ 123.4 ppm & + 260 ppm respectively) as noted above were 
applied as part of the acquisition pulse sequence. A wait period of 5 minutes between on- and off-resonant images 
was provided to ensure that all xenon gas had washed out of the blood stream. For some acquisitions, the images 
with off-resonant saturation pre-pulses were applied first followed by the images with on-resonant saturation 
pre-pulses. In other acquisitions the images with on-resonant saturation pre-pulses were applied first. We did 
this to account for a possible ordering effect to ensure that we were indeed measuring the depolarization of Xe 
because of the saturation pre-pulses and not the depolarization of xenon with time. Images were analyzed using 
custom written MATLAB image processing scripts in a method similar to that presented by Klippel et al.23 and 
detailed in the Supplementary Information. Briefly, SNR maps were created by dividing each pixel of the MR 
image by the standard deviation of the noise (see SI). A convolution filter consisting of a 3 × 3 array that approx-
imates a Gaussian distribution with a normalization factor to maintain signal intensity was applied to smooth 
the images. Saturation maps were produced by the pixel-by-pixel subtraction of the on-resonance image from 
the off-resonance 129Xe images followed by dividing by the off-resonance image. Background noise was removed 
using a mask consistent with established image processing protocols23. Background signal noise outside of the coil 
was segmented and removed using a mask for Fig. 4, for better image clarity so the underlying localizer MRI of 
anatomical structures are clearly visible. The HyperCEST saturation maps were overlaid onto the 1H images using 
GIMP image processing software. A complete explanation of the image processing details and the Matlab script 
is provided in the Supplementary Information.
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